文献速递神经介入外周血管DSA

日本硬脑膜动静脉瘘血管内治疗十三年趋势与进展:基于全国性6470例手术研究的洞察

Thirteen-Year Trends and Advancements of Endovascular Therapy for Dural Arteriovenous Fistulas in Japan: Insights from a Nationwide Study of 6470 Procedures.
PubMed 文献 · AJNR Am J Neuroradiol · 2025-11-03

基于日本神经血管内治疗登记数据库2007至2019年6470例硬脑膜动静脉瘘血管内治疗手术,比较三个时期患者特征、治疗方式与结局;经动脉栓塞中沉淀性液体栓塞材料使用增至31.7%,单纯经动脉栓塞完全闭塞率增至38.0%,30天并发症率、致残率及死亡率无显著变化,高级培训医师监督显著减少并发症。

要点

  • 经动脉栓塞中沉淀性液体栓塞材料使用率增至31.7%,单纯经动脉栓塞完全闭塞率增至38.0%。
  • 30天并发症率、致残率及死亡率在三个时期无显著变化。
  • 高级培训医师监督显著减少并发症。

核心结论

  • 沉淀性液体栓塞材料的使用改善了经动脉栓塞的结局,但其使用也成为并发症的新危险因素,高级培训医师监督可减轻这些风险。

研究设计与样本

  • 基于日本神经血管内治疗登记数据库的多中心登记研究,纳入2007至2019年6470例硬脑膜动静脉瘘血管内治疗手术,比较JR-NET2(2007-2009)、JR-NET3(2010-2014)和JR-NET4(2015-2019)三个时期,采用多因素logistic回归分析预测并发症。

关键影像表现/征象

  • 小脑幕和颅前窝硬脑膜动静脉瘘的治疗量增加。
  • 经动脉栓塞中沉淀性液体栓塞材料使用率增至31.7%。

诊断标准与关键数值

  • 单纯经动脉栓塞的完全闭塞率增至38.0%。
  • JR-NET2和3中,并发症与海绵窦、小脑幕、颅前窝及急诊治疗显著相关。
  • JR-NET4中,侵袭性症状和沉淀性液体栓塞材料与并发症显著相关。
  • 高级培训医师监督显著减少并发症。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Endovascular therapy for dural arteriovenous fistulas (dAVFs) has evolved with advancements in imaging technology and devices. However, few large-scale, nationwide studies have been reported. This study aimed to investigate the trends and advancements in endovascular therapy for dAVFs during the past 13 years.

MATERIALS AND METHODS: We identified patients from the Japanese Registry of Neuroendovascular Therapy (JR-NET) database treated for dAVFs between 2007 and 2019. We compared patient demographics, disease characteristics, treatment methods, and outcomes for JR-NET2 (2007-2009), JR-NET3 (2010-2014), and JR-NET4 (2015-2019). Prediction of complications was evaluated using multivariate logistic regression analysis.

RESULTS: In total, we analyzed 6470 procedures. When we compared JR-NET2, 3, and 4, we found that the treatment for tentorial and anterior cranial fossa dAVFs has increased, and the use of precipitating liquid materials in transarterial embolization (TAE) increased to 31.7%. Complete obliteration in TAEs alone increased to 38.0%, with no significant changes in complication rates, morbidity, or mortality at 30 days. In JR-NET2 and 3, complications were significantly associated with the cavernous sinus, tentorium, anterior cranial fossa, and emergency treatment. In JR-NET4, aggressive symptoms and precipitating liquid embolic materials were significantly correlated with complications. Supervision by senior trainers significantly reduced complications.

CONCLUSIONS: The use of precipitating liquid embolic materials has improved TAE outcomes. While their use has also emerged as a new risk factor for complications, supervision by senior trainers has been shown to mitigate these risks.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Murai S, Hishikawa T, Hiramatsu M, et al. Thirteen-Year Trends and Advancements of Endovascular Therapy for Dural Arteriovenous Fistulas in Japan: Insights from a Nationwide Study of 6470 Procedures. AJNR Am J Neuroradiol. 2025. PMID: 40389268. doi:10.3174/ajnr.A8840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。